H.R.1432 - Federal Government
To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market. |
Referred to the Subcommittee on Commerce, Trade and Consumer Protection.03/12/2007- Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.03/09/2007
- Referred to House Energy and Commerce03/09/2007
- Referred to House Judiciary03/09/2007
ok 
cancel